Navigation Links
DATATRAK International Reports Fourth Quarter and Full Year Results for 2007
Date:2/26/2008

The gross profit margin for the fourth quarter was 48% compared to 66% the same period a year ago. The decline in gross profit margin continues to be the result of the significant decrease in revenue partially offset by a 28% reduction in direct costs.

DATATRAK's backlog at December 31, 2007 was $13.0 million and backlog currently stands at approximately $12.6 million. This compares to a backlog of $12.2 million at December 31, 2006. Backlog is defined as the remaining value of signed contracts or authorization letters to commence services. The Company does not include in its backlog potential contracts or authorization letters that have passed the verbal stage, but have not been signed. All contracts are subject to possible delays or cancellation or can change in scope in a positive or negative direction. Therefore, current backlog is not necessarily indicative of the Company's future quarterly or annual revenue. Historically, backlog has been a poor predictor of the Company's short-term revenue.

"The year of 2007 proved to be a challenging one for DATATRAK, as the clinical trials market was not as responsive or timely to our offerings as we had anticipated, despite the fact that the completeness and functionality of our technology platform has been recognized by groups such as Forrester, Gartner, NTT DATA and multiple experienced clients," stated Dr. Jeffrey A. Green, President and Chief Executive Officer of DATATRAK International, Inc. "Despite the delays with the traction of our platform in the marketplace, signs abound that this industry will eventually gravitate to a broad 'eClinical' set of offerings and will even move beyond that with linkages to patient health information systems and the establishment of longitudinal registry information capabilities. DATATRAK possesses the most seamless capabilities available in this market, and when coupled with our broad set of applications, we remain confident that we will be able to capitalize on
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. DATATRAK International Management to Host Conference Call on February 26, 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007
2. DATATRAK Closes Second Multi-Year Enterprise Agreement with European Clinical Trial Sponsor
3. DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference
4. DATATRAK International Launches Innovative, Interactive Educational Webcast Series
5. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
6. DATATRAK International Management To Host Conference Call on November 8, 2007 To Discuss Third Quarter and Nine Month Operating Results for 2007
7. PRA International to Open Expanded Clinical Pharmacology Center
8. International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as its First and Only Official Joint and Muscle Topical Cream
9. 2008 International Stroke Conference Highlights Impact of Merci Retrieval System
10. Pezcoller Foundation-AACR International Award for Cancer Research recognizes Axel Ullrich
11. Logistical information for the 2008 International Stroke Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... never felt so good for "The Biggest Loser" Danny ... continuing to make smart choices everyday to help him ... choice that is an important part of living well. ... glass of milk has nine essential nutrients like protein ... pressure, and calcium and vitamin D for strong bones. ...
(Date:12/16/2009)... most widely used human embryonic stem cell lines lack ... that must be addressed to ensure that all sectors ... a University of Michigan research team. ,, In the ... analyzed 47 embryonic stem cell lines, including most of ... scientists determined the genetic ancestry of each line and ...
(Date:12/16/2009)... second, possibly deadly, attack is long-term goal, researchers say ... have developed a tool to predict whether a patient ... a first stroke. , "This is an important new ... a second stroke soon after a first stroke are ... Hakan Ay, of Massachusetts General Hospital and Harvard Medical ...
(Date:12/16/2009)... Research teams led by the Wellcome Trust Sanger Institute ... , All cancers are caused by mutations in the ... person,s lifetime. The studies, of a malignant melanoma and ... all the mutations in the genomes of two cancers. ... each year: almost all are associated with smoking. The ...
(Date:12/16/2009)... essential fatty acids commonly found in fatty fish ... to research published by the American Psychological Association. ... problems found in people with schizophrenia; bipolar, obsessive-compulsive, ... afflictions of the nervous system. , The ... , provides more evidence that fish is brain ...
Breaking Medicine News(10 mins):Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:New study links DHA type of omega-3 to better nervous-system function 2
... announced today the publication of results of a Phase ... is an,effective treatment for relief of moderate to severe ... study was to evaluate the efficacy and,safety of three ... 0.25 mg/day,including the lowest approved dose of estradiol gel ...
... Patient MonitoringMOUNTAIN VIEW, Calif., Feb. 17 Based ... monitoring market, Frost & Sullivan recognizes Strategic Healthcare ... Frost & Sullivan Growth Enabling Technology Award for ... market needs. There is a desperate demand in ...
... VeriFone Holdings,Inc. (NYSE: PAY ) ... been integrated with Secure EDI,s state-of-the-art platform to ... Secure EDI is a ... for medical, dental and institutional providers. The,company also ...
... Feb. 17 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc. (BMR.TSX), ... III GLASS-ART Trial testing Neuradiab(R) in the most ... announced that its Board of Directors has recommended ... performance, market conditions and new projections of site ...
... 17 Cardiac Science (Nasdaq: CSCX ), ... and informatics products, today announced today that it will ... Conference at the Ritz Carlton Laguna Nigel. John Hinson, ... business strategy and recent financial results during the Company,s ...
... WEST BABYLON, N.Y., Feb. 17 New paintbrush ... by the ArroWorthy Co. NY, is designed to ... ergonomically contoured handle allows a variety of gripping ... hook is incorporated for on job resting or ...
Other Medicine News:Health News:Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause 2Health News:Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause 3Health News:Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause 4Health News:Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation 2Health News:Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation 3Health News:Secure EDI Integrates VeriFone IPCharge in Real Time Patient Payment and Claims Processing Solutions Suite 2Health News:Secure EDI Integrates VeriFone IPCharge in Real Time Patient Payment and Claims Processing Solutions Suite 3Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 2Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 3Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 4Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 2Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 3Health News:Efficient and Comfortable, the Right Brush(R) is the First Revolution in Painting Since the Roller 2Health News:Efficient and Comfortable, the Right Brush(R) is the First Revolution in Painting Since the Roller 3
(Date:12/16/2009)... 16 Scientists at,deCODE genetics, Inc. (Nasdaq: ... of a version of a common single-letter variant ... a major impact on susceptibility to type 2,diabetes ... not only large, but unusual:,if an individual inherits ... of,T2D by more than 30% compared to those ...
(Date:12/16/2009)... Cohera Medical Inc. today announced the ... of its lead surgical adhesive product, TissuGlu®. Initiation ... the company,s progression of the lead product toward ... a prospective, open-label, randomized study to investigate the ... drainage and associated complications in abdominoplasty, or "tummy ...
(Date:12/16/2009)... 16 CareCentrix, Inc ., the ... services, announced today that it has been awarded ... health care accrediting organization that establishes quality standards ... that only appropriately trained, qualified clinical personnel conduct ... reasonable and timely appeals process is in place, ...
Breaking Medicine Technology:deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 3CareCentrix Receives URAC Health Utilization Management Accreditation 2Increased Spending on the EUs External Borders to Drive the Border Security Market Says Frost 26amp 3B Sullivan 11160 1Increased Spending on the EUs External Borders to Drive the Border Security Market Says Frost 26amp 3B Sullivan 11160 2Increased Spending on the EUs External Borders to Drive the Border Security Market Says Frost 26amp 3B Sullivan 11160 3Request A Test Receives Weatherhead 100 Upstart Award 63372 1Request A Test Receives Weatherhead 100 Upstart Award 63372 2New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 63367 1New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 63367 2
... - Panacos,Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company,dedicated ... products, today announced the results of a ... Inhibitors (PI) may have,reduced potential for the ... bevirimat in laboratory assays. The study,carried out ...
... /PRNewswire/ -- D-Pharm announced,today that the results of ... in the treatment of acute ischemic,stroke patients will ... will be presented by the study's German,principal investigator ... at,14.30 in the Carron Room, at the Scottish ...
Other Medicine Technology:Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 2Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 3DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 2DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 3
... Varicella-Zoster Virus (VZV) IgG Enzyme-Linked Immunosorbent Assay ... quantitative determination of IgG antibody to VZV ... may be used for the determination of ... may be used to demonstrate seroconversion or ...
... Scientific, Inc. Mumps IgG ELISA test system ... Mumps IgG antibody in human serum. When ... of this test, together with other clinical ... immune status, and/or aid in the diagnosis ...
... The Trinity Biotech Mumps IgM ... intended for the qualitative detection ... serum to Mumps for the ... performance characteristics of this kit ...
The CALBIOTECH, INC. (CBI), Mumps IgM ELISA tests system is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Mumps in human serum or plasma....
Medicine Products: